![](https://webarchive.library.unt.edu/eot2008/20090201132726im_/http://www.cancer.gov/images/spacer.gif) |
|
1. Radiation and Chemo Before Esophageal Cancer Surgery Improves Survival (Posted: 08/21/2007) - Preoperative (neoadjuvant) use of combination chemoradiotherapy helped patients with localized esophageal cancer to live longer, according to the March 2007 Lancet Oncology.
![](https://webarchive.library.unt.edu/eot2008/20090201132726im_/http://www.cancer.gov/images/spacer.gif)
2. Patients With Esophageal Cancer May Be Able to Avoid Surgery (Posted: 04/16/2007) - Patients with esophageal cancer lived just as long after receiving chemoradiation therapy alone as did those whose chemoradiation therapy was followed by surgery, according to the April 1, 2007, Journal of Clinical Oncology.
![](https://webarchive.library.unt.edu/eot2008/20090201132726im_/http://www.cancer.gov/images/spacer.gif)
3. New Chemotherapy Regimen Extends Survival for Patients with Resectable Gastric Cancer (Posted: 07/12/2006) - When it comes to chemotherapy for locally invasive gastric cancer, results from an international clinical trial published in the July 6, 2006, issue of the New England Journal of Medicine suggest that timing can make all the difference.
![](https://webarchive.library.unt.edu/eot2008/20090201132726im_/http://www.cancer.gov/images/spacer.gif)
4. Frozen Glove Reduces Skin and Nail Damage from Docetaxel Chemotherapy (Posted: 08/01/2005) - Patients who wore an experimental "frozen glove" to keep their hands very cold during intravenous chemotherapy with docetaxel (Taxotere®) had much less subsequent damage to the nails and skin of their hands, according to a study published in the July 1, 2005, issue of the Journal of Clinical Oncology.
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201132726im_/http://www.cancer.gov/images/spacer.gif) |